| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7633954 | Journal of Proteomics | 2018 | 12 Pages |
Abstract
The glycoproteome is an important source of cancer biomarkers holding tremendous potential for targeted therapeutics. We now present an in silico roadmap for comprehensive interpretation of big data generated by mass spectrometry-based glycoproteomics envisaging the identification of clinically relevant glycobiomarkers.
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Rita Azevedo, André M.N. Silva, Celso A. Reis, Lúcio Lara Santos, José Alexandre Ferreira,